期刊文献+

沉默CD98hc表达对乳腺癌细胞MDA-MB-231增殖、侵袭的影响

Effect of silencing CD98hc expression on MDA-MB-231 breast cancer cells proliferation and invasion
在线阅读 下载PDF
导出
摘要 目的观察沉默CD98hc对乳腺癌MDA-MB-231细胞体外增殖、迁移及侵袭的影响。方法应用RNA干扰技术沉默乳腺癌MDA-MB-231细胞CD98hc的表达,筛选并获得稳定CD98hc低表达的MDA-MB-231细胞株(CD98hc-shRNA)及对照组细胞(Vector)。应用Western blot及qRT-PCR技术鉴定CD98hc的表达;应用MTT细胞增殖实验检测细胞增殖能力的改变;细胞迁移侵袭实验检测细胞迁移和侵袭能力的改变。结果 CD98hc-shRNA下调乳腺癌MDA-MB-231细胞CD98hc的表达,与空白组(0.706±0.013)、对照组(0.724±0.018)相比,实验组(0.580±0.035)细胞的增殖能力明显下调(P<0.05),且迁移和侵袭能力也显著受抑制(P<0.05),空白组与对照组差异无统计学意义(P>0.05)。结论 CD98hc可能参与乳腺癌细胞生物学行为的调控。 Purpose To investigate the effect of silencing of CD98bc on proliferation, migration and invasion of MDA-MB- 231 breast cancer cells. Methods RNA interfere technology was used to silence CD98hc in MDA-MB-231 cells. MDA-MB- 231 cells (CD98he-shRNA) with stable low expression of CD98hc and Vector control was obtained. Western blot and qRT-PCR were used to verify the down-regulation of CD98hc. MTT assay was used to test the cell proliferation. Transwell mi- gration and invasion experiment were used to assay cell migration and invasion. Results The expression levels of CD98hc was down-regulated by CD98hc-shRNA in the MDA-MB-231 breast cancer cells. Compared to that of blank cells (0. 706 ±0. 013) , vector control (0. 724 ±0.018 ), the cell proliferation potency of CD98hc-shRNA cells (0. 580 ±0. 035) was significantly inhibi- ted ( P 〈 0. 05 ) , and the cell migration and invasion potency al- so were inhibited ( P 〈 0. 05 ), there is on significant different between blank cells and vector control ( P 〈 0. 05 ). Conclusion CD98hc might be involved in the regulation of breast cancer cell biological behaviors.
出处 《临床与实验病理学杂志》 CSCD 北大核心 2017年第11期1199-1202,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(81372476 81472493)
关键词 乳腺肿瘤 CD98hc 细胞增殖 细胞侵袭 breast neoplasm CD98hc cell proliferation cellinvasion
  • 相关文献

参考文献2

二级参考文献20

  • 1Morgan LU The epidemiology of glioma in aduhs:a "state of the science" review [J]. Neuro Oncol,2015,17(4) :623-624.
  • 2Cloughesy TF, Cavenee WK, Mischel PS. Glioblastoma : from molecular pathology to targeted treatment [J]. Annu Rev Pathol, 2014,9( 1 ): 1-25.
  • 3Wen PY,Reardon DA. Neuro-oneology in 2015:Progress in glioma diagnosis, classification and treatment [J]. Nat Rev Neurol, 2016,12 (2) : 69-70.
  • 4Krishnatry R,Zhukova N, Guerreim SA, et al. Clinical and treatment factors determining long-term outcomes for adult survivors of ehildhood low-grade glioma:A popula- tion-based study [J]. Cancer,2016,122(8) : 1261-1269.
  • 5Rosell A,Meury M,Alvarez-Marimon E,et al. Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc [J]. Proc Natl Aead Sci U S A, 2014,111 (8):2966- 2971.
  • 6Theodosakis N, Mieevie G, Sharma R, et al. Integrative discovery of CD98 as a Melanoma Biomarker [J]. Pigment Cell Melanoma Res, 2016,29(3) : 385-387.
  • 7Haining Z,Kawai N,Miyake K,et al. Relation of LAT1/ 4F2hc expression with pathological grade,proliferation andangiogenesis in human gliomas [J]. BMC Clin Pathol, 2012,12(1) :4.
  • 8Haynes BF. Human T lymphocyte antigens as defined by rnonoclonal antibodies [J]. Immunol Rev, 1981,57(1) : 127- 161.
  • 9Wu B, Wang Y, Yang XM, et al. Basigin-mediated redis- tribution Of CD98 promotes cell spreading and tumori- genicity in hepatocellular carcinoma [J]. J Exp Clin Can- cer Res ,2015,34(10) : 110.
  • 10Furuya M,Horiguchi J,Nakajima H,et al. Correlation of L-type amino acid transporter 1 and CI)98 expression with triple negative breast cancer prognosis [J]. Cancer Sci, 2012,103(2) : 382-389.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部